BSACI Registry for Immunotherapy (BRIT): Providing safe and effective immunotherapy for allergies and urticaria

Sujoy Khan¹, Mamidipudi Thirumala Krishna^{2

3

4}, Louise J Michaelis^{5

6}, Tom C Dawson⁷, Deborah Marriage⁸, Anna Thursby-Pelham⁸, Leyla Pur Özyiğit⁹, Carla Jones¹⁰, Lynne Regent¹¹, Mich Erlewyn-Lajeunesse¹²

Affiliations

¹ Immunology & Allergy, Hull University Teaching Hospitals NHS Trust, Castle Hill Hospital, Hull, UK.
² Department of Allergy and Immunology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
³ Institute of Immunology and Immunotherapy, Institute of Clinical Sciences, University of Birmingham, Birmingham, UK.
⁴ IQAS Accreditation Programme, Accreditation Unit, The Royal College of Physicians, London, UK.
⁵ Paediatric Immunology, Allergy & Infectious Diseases, Great North Children's Hospital, Newcastle upon Tyne, UK.
⁶ Institute of Population Health Sciences, Newcastle University, Newcastle upon Tyne, UK.
⁷ Paediatric Department, Worcestershire Acute Hospitals NHS Trust, Worcester, UK.
⁸ Department of Paediatrics, Bristol Royal Hospital for Children, Bristol, UK.
⁹ Department of Allergy, University Hospitals Leicester NHS Trust, Leicester, UK.
¹⁰ Allergy UK, Sidcup, UK.
¹¹ Anaphylaxis Campaign, Farnborough, UK.
¹² Department of Paediatric Allergy, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Editorial

Sujoy Khan et al. Clin Exp Allergy. 2021 Aug.

. 2021 Aug;51(8):985-988.

doi: 10.1111/cea.13887.

¹ Immunology & Allergy, Hull University Teaching Hospitals NHS Trust, Castle Hill Hospital, Hull, UK.
² Department of Allergy and Immunology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
³ Institute of Immunology and Immunotherapy, Institute of Clinical Sciences, University of Birmingham, Birmingham, UK.
⁴ IQAS Accreditation Programme, Accreditation Unit, The Royal College of Physicians, London, UK.
⁵ Paediatric Immunology, Allergy & Infectious Diseases, Great North Children's Hospital, Newcastle upon Tyne, UK.
⁶ Institute of Population Health Sciences, Newcastle University, Newcastle upon Tyne, UK.
⁷ Paediatric Department, Worcestershire Acute Hospitals NHS Trust, Worcester, UK.
⁸ Department of Paediatrics, Bristol Royal Hospital for Children, Bristol, UK.
⁹ Department of Allergy, University Hospitals Leicester NHS Trust, Leicester, UK.
¹⁰ Allergy UK, Sidcup, UK.
¹¹ Anaphylaxis Campaign, Farnborough, UK.
¹² Department of Paediatric Allergy, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

No abstract available

References

1. Vance GH, Goldring S, Warner JO, et al. A national audit of pollen immunotherapy for children in the United Kingdom: patient selection and programme safety. Clin Exp Allergy. 2011;41:1313-1323.
1. Rajakulasingam RK, Farah N, Huber PAJ, et al. Practice and safety of allergen-specific immunotherapy for allergic rhinitis in the UK national health service: a report of "real world" clinical practice. Clin Exp Allergy. 2018;48:89-92.
1. Subramanian A, Adderley NJ, Gkoutos GV, Gokhale KM, Nirantharakumar K, Krishna MT. Ethnicity-based differences in the incident risk of allergic diseases and autoimmune disorders: a UK-based retrospective cohort study of 4.4 million participants. Clin Exp Allergy. 2021;51:144-147.
1. Erlewyn-Lajeunesse M, Kinsman R, Walton P. First BSACI registry for immunotherapy report. Reading, UK: Dendrite Clinical Systems Ltd; 2021. ISBN 978-1-9160207-5-7 www.bsaci.org.
1. Paoletti G, DiBona D, Chu DK, et al. Allergen immunotherapy: the growing role of observational and randomisedtrial "real-world evidence". Allergy. 2021. https://doi.org/10.1111/all.14773